Heska Corp (NASDAQ:HSKA)

28.68
Delayed Data
As of May 01
 +0.59 / +2.10%
Today’s Change
10.38
Today|||52-Week Range
31.87
+58.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$185.9M

Company Description

Heska Corp. develops, manufacture, market, sell and support veterinary products. The company focuses on the canine and feline companion animal health markets. It operates its business through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment includes primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment includes private label vaccine and pharmaceuticals, primarily for cattle as well as for other animals, including small mammals. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Contact Information

Heska Corp.
3760 Rocky Mountain Avenue
Loveland Colorado 80538
P:(970) 493-7272
Investor Relations:

Employees

Shareholders

Mutual fund holders8.31%
Other institutional28.10%
Individual stakeholders20.71%

Top Executives

Kevin S. WilsonPresident, Chief Executive Officer & Director
Jason A. NapolitanoChief Financial Officer, Secretary & Executive VP
Laurie E. PetersonVice President-Technical Operations
Nancy WisnewskiEVP-Product Development & Customer Support
Michael J. McGinleyPresident-Biologicals & Pharmaceuticals

To view my watchlist

Not a member yet?

Sign up now for a free account